ArticleCureus2026
Clinical, Bacterial, and Antibiogram Profiles of Infections Among Type 2 Diabetes Mellitus Patients in a Tertiary Care Center.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Patients with type 2 diabetes mellitus (T2DM) have an increased susceptibility to infection because of hyperglycemia-related immune dysfunction, vascular impairment, and associated comorbidities. Characterization of bacterial isolates and their antimicrobial susceptibility patterns is essential for selecting appropriate empirical therapy and limiting antimicrobial resistance. Methodology This hospital-based, cross-sectional study included 150 adults with T2DM and culture-positive infections admitted to a tertiary care hospital in Bengaluru, India, between April 2023 and November 2024. Clinical and microbiological characteristics, HbA1c levels, intensive care unit (ICU) admission, and in-hospital mortality were assessed. Bacterial identification, antimicrobial susceptibility testing, and extended-spectrum beta-lactamase (ESBL) assessment were performed by the hospital microbiology laboratory as part of routine clinical care, with susceptibility results reported according to the applicable Clinical and Laboratory Standards Institute criteria. Results Urinary tract infection was the most frequent infection, affecting 55/150 patients (36.67%).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.